Disease areas

Biotech companies by disease area

The companies we cover, grouped by the diseases their open catalysts and active programs target. A company working in several areas appears in each.

• Blood cancers
  32 companies · 20 upcoming catalysts
  Leukemia, lymphoma, myeloma and related cancers
• Lung cancer
  32 companies · 15 upcoming catalysts
  Non-small cell and small cell lung cancer and mesothelioma
• Breast and gynecologic cancers
  35 companies · 12 upcoming catalysts
  Breast, ovarian, endometrial and cervical cancer
• Gastrointestinal cancers
  39 companies · 16 upcoming catalysts
  Colorectal, pancreatic, gastric, liver and biliary cancer
• Other cancers
  65 companies · 55 upcoming catalysts
  Prostate, bladder, kidney, skin, brain, head and neck cancers, sarcomas and solid tumors in general
• Eye diseases
  22 companies · 27 upcoming catalysts
  Retinal disease, macular degeneration, uveitis and other eye conditions
• Kidney diseases
  25 companies · 11 upcoming catalysts
  IgA nephropathy, lupus nephritis, FSGS and other kidney conditions
• Neuromuscular diseases
  28 companies · 26 upcoming catalysts
  Muscular dystrophies, myasthenia gravis, myositis and related conditions
• Neurology and pain
  68 companies · 45 upcoming catalysts
  ALS, Alzheimer's, Parkinson's, multiple sclerosis, epilepsy, pain and other nervous system conditions
• Psychiatric disorders
  21 companies · 11 upcoming catalysts
  Depression, schizophrenia, anxiety, PTSD, addiction and related conditions
• Blood disorders
  15 companies · 6 upcoming catalysts
  Sickle cell disease, thalassemia, hemophilia, PNH and other non-cancer blood conditions
• Infectious diseases
  16 companies · 8 upcoming catalysts
  Hepatitis B and D, COVID-19, influenza, RSV, bacterial infections and vaccines
• Lung and respiratory diseases
  24 companies · 7 upcoming catalysts
  Pulmonary hypertension, pulmonary fibrosis, asthma, COPD and cystic fibrosis
• Liver and digestive diseases
  26 companies · 18 upcoming catalysts
  MASH, ulcerative colitis, Crohn's disease, cholestatic liver disease and other digestive conditions
• Obesity, diabetes and heart disease
  47 companies · 40 upcoming catalysts
  Obesity, diabetes, high cholesterol, heart failure, cardiomyopathy and other heart conditions
• Skin diseases
  26 companies · 21 upcoming catalysts
  Atopic dermatitis, psoriasis, hidradenitis suppurativa, alopecia, wounds and other skin conditions
• Autoimmune and inflammatory diseases
  53 companies · 25 upcoming catalysts
  Rheumatoid arthritis, lupus, Sjögren's disease, gout, transplant rejection and other immune conditions
• Endocrine and bone diseases
  15 companies · 10 upcoming catalysts
  Thyroid, parathyroid, growth and pituitary disorders, menopause and bone diseases
• Rare genetic and metabolic diseases
  26 companies · 15 upcoming catalysts
  Enzyme deficiencies, lysosomal storage diseases, ATTR amyloidosis and other inherited conditions